- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01826539
A Comparison of Dorsal Branch of the Digital Nerve Versus Dorsal Digital Nerve for Finger Pulp Reconstruction
April 5, 2013 updated by: The Second Hospital of Tangshan
As the donor nerve attached with the flap, the dorsal branch of the digital nerve and the dorsal digital nerve is commonly used for finger pulp reconstruction.This study compares two donor nerves: the dorsal branch of the digital nerve and the dorsal digital nerve.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The investigators compares two donor nerves attached with the flap for sensory reconstruction of finger pulp: the dorsal branch of the digital nerve and the dorsal digital nerve.
The main outcomes were static 2-point discrimination and Semmes-Weinstein monofilament scores of the flap, and pain and cold intorlence of the reconstructed finger.
Study Type
Interventional
Enrollment (Actual)
71
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hebei
-
Tangshan, Hebei, China, 063000
- The Second Hospital of Tangshan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 55 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The pulp or fingertip defect in only one finger
- A defect greater than or equal to 1.5 cm in length
- Necessity to preserve finger length
- A patient between 18 and 60 years of age
Exclusion Criteria:
- Injuries to the dorsum of the middle phalanx
- Injuries to the course of the vascular pedicle or donor nerve
- A defect less than 1.5 cm in length
- Multiple finger pulp defect
- Extremely contaminated wounds
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Innervated finger flap
donor nerve attached with the flap for finger pulp reconstruction
|
the donor nerve is attached with the flap for sensory reconstruction of the finger
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
static 2-point discrimination (2PD) test
Time Frame: 18 months to 26 months
|
The test points are at the center of the radial or ulnar portion of the pulp.
Each area is tested 3 times with a Discriminator.
We stop at 4mm as a limit of 2PD and consider this normal.
|
18 months to 26 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cold intolerance
Time Frame: 18 months to 26 months
|
Cold intolerance in the reconstructed finger is assessed using the self-administered Cold Intolerance Severity Score questionnaire [10].
The maximum score is 100 and was group into 4 ranges (0-25, 26-50, 51-75, and 76-100), corresponding to mild, moderate, severe, and extreme severity, respectively.
|
18 months to 26 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain
Time Frame: 18 months to 26 months
|
Using the visual analogue scale (VAS), patients are asked to report pain sensations of the reconstructed pulps and donor sites.
The VAS consists of a 10 cm line that is grouped into mild (0-3 cm), moderate (4-6 cm) and severe (7-10 cm).
|
18 months to 26 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Dequn Liu, MD. PhD, The Second Hospital of Tangshan
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
February 1, 2012
Study Completion (Actual)
September 1, 2012
Study Registration Dates
First Submitted
April 1, 2013
First Submitted That Met QC Criteria
April 5, 2013
First Posted (Estimate)
April 8, 2013
Study Record Updates
Last Update Posted (Estimate)
April 8, 2013
Last Update Submitted That Met QC Criteria
April 5, 2013
Last Verified
April 1, 2011
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TSChen8652
- HBTS13-03095 (Other Identifier: Ethics Committee of Hebei)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.